新股消息 | 新济医药、翼菲科技等拟香港IPO获中国证监会接收材料

智通财经
Jan 30

智通财经APP获悉,1月30日,中国证监会发布《境内企业境外发行证券和上市备案情况表(首次公开发行及全流通)(截至2026年1月30日)》,其中,新济医药、翼菲科技、导远科技、车联天下、唯迈医疗、景旺电子、君赛生物、主线科技拟香港IPO获中国证监会接收材料;老乡鸡(间接境外上市)拟香港IPO备案状态为征求意见;芯迈半导体拟香港IPO备案状态为补充材料。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10